Fortress Biotech Inc

NASDAQ:FBIO   11:29:02 AM EDT
2.11
-0.06 (-2.76%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)38.78M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$14.46 Million
Adjusted EPS-$2.08
See more estimates
10-Day MA$2.00
50-Day MA$1.95
200-Day MA$21.29
See more pivots

Fortress Biotech Inc Stock, NASDAQ:FBIO

1111 Kane Concourse, Suite 301, Bay Harbor Islands, Florida 33154
United States of America
Phone: +1.781.652.4500
Number of Employees: 187

Description

Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded in 2006 and is headquartered in Bay Harbor Islands, FL.